Showing results (501-510 of 566) with videos related to

Sort By:
Pageof 57
Leukemia|August 22, 2003
Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAILW-S Suh, Y S Kim, A D Schimmer, et al.
The Journal of Clinical Investigation|September 19, 2001
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemiaM Milella, S M Kornblau, Z Estrov, et al.
Blood|April 1, 1980
Heterogeneity of cell lineages in L3 leukemiasB Koziner, R Mertelsmann, M Andreeff, et al.
Blood|November 1, 1995
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.
The New England Journal of Medicine|September 9, 1993
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantationS Giralt, S Escudier, H Kantarjian, et al.
Blood|September 1, 1996
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytesJ Drach, A Gsur, G Hamilton, et al.
British Journal of Haematology|December 24, 1997
Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignanciesV Snell, K Clodi, S Zhao, et al.
British Journal of Haematology|March 22, 2001
Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplificationK Pachmann, S Zhao, T Schenk, et al.
Leukemia|May 21, 1998
Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemiaT M Schenk, A Keyhani, S Bottcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogeneticsS M Kornblau, P F Thall, Z Estrov, et al.
Pageof 57